5 testosterone , free testosterone , and free androgen index in women : reference intervals , biological variation , and diagnostic value in polycystic ovary syndrome

INTRODUCTION. The introduction of more accurate methods for testosterone analysis, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) or next-generation immunoassays, may

[1]  D. Knol,et al.  Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC–MS/MS method and a 2nd generation automated immunoassay , 2013, Steroids.

[2]  R. Fitzgerald,et al.  Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the Partnership for the Accurate Testing of Hormones. , 2012, Clinical chemistry.

[3]  A. Balen,et al.  Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots. , 2010, European journal of endocrinology.

[4]  David J Handelsman,et al.  Predictive accuracy and sources of variability in calculated free testosterone estimates , 2009, Annals of clinical biochemistry.

[5]  F. Montorsi,et al.  Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. , 2008, The journal of sexual medicine.

[6]  S. Atkin,et al.  Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia , 2008, Clinical endocrinology.

[7]  A. Balen,et al.  The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research , 2007, Clinical endocrinology.

[8]  R. Norman,et al.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  D. Grobbee,et al.  Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. , 2006, Clinical chemistry.

[10]  S. Vesely,et al.  Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  Ricardo Azziz,et al.  Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. , 2005, Fertility and sterility.

[12]  N. Skakkebaek,et al.  Variation in levels of serum inhibin B, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone, and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  J. L. San Millán,et al.  Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. , 2001, European journal of endocrinology.

[14]  J. M. Christensen,et al.  Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women. , 2000, Clinical chemistry.

[15]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[16]  T. Key,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .

[17]  R. Huupponen,et al.  Biological Day-to-Day Variation and Daytime Changes of Testosterone, Follitropin, Lutropin and Oestradiol-17β in Healthy Men , 1998, Clinical chemistry and laboratory medicine.

[18]  M. Maes,et al.  Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers , 1997, Clinical endocrinology.

[19]  Jean-Claude Libeer,et al.  Proposals for Setting Generally Applicable Quality Goals Solely Based on Biology , 1997, Annals of clinical biochemistry.

[20]  C. Ricós,et al.  Quality Goals for Hormone Testing , 1990, Annals of clinical biochemistry.

[21]  Dolian Gg,et al.  Diagnostic criteria for polycystic ovary syndrome , 1989 .

[22]  M. Bissell.  Accuracy of 6 Routine 25-Hydroxyvitamin D Assays: Influence of Vitamin D Binding Protein Concentration , 2013 .

[23]  R. Kries,et al.  Accuracy of First and Second Generation Testosterone Assays and Improvement through Sample Extraction , 2012 .

[24]  B. Keevil,et al.  State-ofthe-Art of Serum Testosterone Measurement by Isotope Dilution – Liquid Chromatography – Tandem Mass Spectrometry , 2012 .

[25]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[26]  C G Fraser,et al.  Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.